Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-12

Clinical Trial Update: Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating mesenchymal stem cells for cerebellar ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: National Yang Ming Chiao Tung University | Conditions: Cerebellar Ataxia | Phase 1, Phase 2 | Status: COMPLETED